Mesenchymal stem cell-like cells from children foreskin inhibit the growth of SGC-7901 gastric cancer cells

Experimental and Molecular Pathology

Volumn 94, Issue 3, 2013, Pages 430-437

  Li, Yahong ^a   Zhao, Yuanyuan ^a   Cheng, Zhihong ^b   Zhan, Jie ^a   Sun, Xiaochun ^a   Qian, Hui ^a   Zhu, Wei ^a   Xu, Wenrong ^a,b  

^a JIANGSU UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Explant culture; Foreskin; Mesenchymal stem cells; Tumor inhibition

Indexed keywords

CASPASE 3; CYCLINE; PROTEIN BAX; PROTEIN BCL 2;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; EXPLANT; FORESKIN MESENCHYMAL STEM CELL LIKE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; OSTEOCYTE; PROTEIN EXPRESSION; STOMACH CANCER; UPREGULATION;

ADENOCARCINOMA; ADIPOCYTES; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; FORESKIN; HUMANS; INFANT, NEWBORN; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OSTEOCYTES; RNA, MESSENGER; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84875661832     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.02.001     Document Type: Article

References (49)

1. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
2. Bergfeld S.A., DeClerck Y.A. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Reviews 2010, 29:249-261.
3. Bi D., Chen F.G., Zhang W.J., Zhou G.D., Cui L., Liu W., Cao Y. Differentiation of human multipotent dermal fibroblasts into islet-like cell clusters. BMC Cell Biology 2010, 11:46.
4. Blanpain C., Fuchs E. Epidermal stem cells of the skin. Annual Review of Cell and Developmental Biology 2006, 22:339-373.
5. Cakouros D., Raices R.M., Gronthos S., Glackin C.A. Twist-ing cell fate: mechanistic insights into the role of twist in lineage specification/differentiation and tumorigenesis. Journal of Cellular Biochemistry 2010, 110:1288-1298.
6. Cavallo C., Cuomo C., Fantini S., Ricci F., Tazzari P.L., Lucarelli E., Donati D., Facchini A., Lisignoli G., Fornasari P.M., Grigolo B., Moroni L. Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies. Journal of Cellular Biochemistry 2011, 112:1418-1430.
7. Choi Y.H., Kurtz A., Stamm C. Mesenchymal stem cells for cardiac cell therapy. Human Gene Therapy 2011, 22:3-17.
8. Deans R.J., Moseley A.B. Mesenchymal stem cells: biology and potential clinical uses. Experimental Hematology 2000, 28:875-884.
9. Djouad F., Bony C., Apparailly F., Louis-Plence P., Jorgensen C., Noël D. Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation 2006, 82:1060-1066.
10. Fernandes K.J., McKenzie I.A., Mill P., Smith K.M., Akhavan M., Barnabé-Heider F., Biernaskie J., Junek A., Kobayashi N.R., Toma J.G., Kaplan D.R., Labosky P.A., Rafuse V., Hui C.C., Miller F.D. A dermal niche for multipotent adult skin-derived precursor cells. Nature Cell Biology 2004, 6:1082-1093.
11. Giuliani M., Oudrhiri N., Noman Z.M., Vernochet A., Chouaib S., Azzarone B., Durrbach A., Bennaceur-Griscelli A. Human mesenchymal stem cells derived from induced pluripotent stem cells downregulate NK cell cytolytic machinery. Blood 2011, 118:3254-3262.
12. Hoogduijn M.J., Gorjup E., Genever P.G. Comparative characterization of hair follicle dermal stem cells and bone marrow mesenchymal stem cells. Stem Cells and Development 2006, 15:49-60.
13. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Largaespada D.A. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
14. Jiang J., Han P., Zhang Q., Zhao J., Ma Y. Cardiac differentiation of human pluripotent stem cells. Journal of Cellular and Molecular Medicine 2012, 16:1663-1668.
15. Kawada M., Ishizuka M., Takeuchi T. Enhancement of antiproliferative effects of interleukin-1beta and tumor necrosis factor-alpha on human prostate cancer LNCaP cells by coculture with normal fibroblasts through secreted interleukin-6. Japanese Journal of Cancer Research 1999, 90:546-554.
16. Khakoo A.Y., Pati S., Anderson S.A., Reid W., Elshal M.F., Rovira I.I., Nguyen A.T., Malide D., Combs C.A., Hall G., Zhang J., Raffeld M., Rogers T.B., Stetler-Stevenson W., Frank J.A., Reitz M., Finkel T. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. The Journal of Experimental Medicine 2006, 203:1235-1247.
17. Lanza C., Morando S., Voci A., Canesi L., Principato M.C., Serpero L.D., Mancardi G., Uccelli A., Vergani L. Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. Journal of Neurochemistry 2009, 110:1674-1684.
18. Lavoie J.F., Biernaskie J.A., Chen Y., Bagli D., Alman B., Kaplan D.R., Miller F.D. Skin-derived precursors differentiate into skeletogenic cell types and contribute to bone repair. Stem Cells and Development 2009, 18:893-906.
19. Lermen D., Gorjup E., Dyce P.W., von Briesen H., Müller P. Neuro-muscular differentiation of adult porcine skin derived stem cell-like cells. PloS One 2010, 5:e8968.
20. Li G.C., Ye Q.H., Xue Y.H., Sun H.J., Zhou H.J., Ren N., Jia H.L., Shi J., Wu J.C., Dai C., Dong Q.Z., Qin L.X. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Science 2010, 101:2546-2553.
21. Ling X., Marini F., Konopleva M., Schober W., Shi Y., Burks J., Clise-Dwyer K., Wang R.Y., Zhang W., Yuan X., Lu H., Caldwell L., Andreeff M. Mesenchymal stem cells overexpressing IFN-β inhibit breast cancer growth and metastases through stat3 signaling in a syngeneic tumor model. Cancer Microenvironment 2010, 3:83-95.
22. Mamidi M.K., Pal R., Mori N.A., Arumugam G., Thrichelvam S.T., Noor P.J., Abdullah H.M., Gupta P.K., Das A.K., Zakaria Z., Bhonde R. Co-culture of mesenchymal-like stromal cells derived from human foreskin permits long term propagation and differentiation of human embryonic stem cells. Journal of Cellular Biochemistry 2011, 112:1353-1363.
23. Marolt D., Campos I.M., Bhumiratana S., Koren A., Petridis P., Zhang G., Spitalnik P.F., Grayson W.L., Vunjak-Novakovic G. Engineering bone tissue from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:8705-8709.
24. Martin F.T., Dwyer R.M., Kelly J., Khan S., Murphy J.M., Curran C., Miller N., Hennessy E., Dockery P., Barry F.P., O'Brien T., Kerin M.J. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Research and Treatment 2010, 124:317-326.
25. Maurer M.H. Proteomic definitions of mesenchymal stem cells. Stem Cells International 2011, 704256.
26. Menen R., Pinney E., Hassanein M.K., Kolostova K., Bobek V., Suetsugu A., Zhang N., Bouvet M., Naughton G.K., Hoffman R.M. Inhibition of metastasis of circulating human prostate cancer cells in the chick embryo by an extracellular matrix produced by foreskin fibroblasts in culture. Anticancer Research 2012, 32:1573-1577.
27. Nishimura K., Semba S., Aoyagi K., Sasaki H., Yokozaki H. Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells. Pathobiology 2012, 79:290-306.
28. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
29. Qian H., Zhang X., Xu W., Zhu W., Cao H., Chen Y., Xu X., Wang M., Xie Y., Sun J. Lentivirus-modified human umbilical cord mesenchymal stem cells maintain their pluripotency. Biotechnology and Applied Biochemistry 2010, 55:53-62.
30. Qiao C., Xu W., Zhu W., Hu J., Qian H., Yin Q., Jiang R., Yan Y., Mao F., Yang H., Wang X., Chen Y. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biology International 2008, 32:8-15.
31. Rodríguez R., García-Castro J., Trigueros C., García Arranz M., Menéndez P. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling. Advances in Experimental Medicine and Biology 2012, 741:187-205.
32. Schwartz R.E., Reyes M., Koodie L., Jiang Y., Blackstad M., Lund T., Lenvik T., Johnson S., Hu W.S., Verfaillie C.M. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. The Journal of Clinical Investigation 2002, 109:1291-1302.
33. Secchiero P., Zorzet S., Tripodo C., Corallini F., Melloni E., Caruso L., Bosco R., Ingrao S., Zavan B., Zauli G. Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. PloS One 2010, 5:e11140.
34. Shi C., Zhu Y., Su Y., Cheng T. Stem cells and their applications in skin-cell therapy. Trends in Biotechnology 2006, 24:48-52.
35. Soria G., Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Letters 2008, 267:271-285.
36. Sun B., Roh K.H., Park J.R., Lee S.R., Park S.B., Jung J.W., Kang S.K., Lee Y.S., Kang K.S. Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model. Cytotherapy 2009, 11:289-298.
37. Tabe Y., Konopleva M., Munsell M.F., Marini F.C., Zompetta C., McQueen T., Tsao T., Zhao S., Pierce S., Igari J., Estey E.H., Andreeff M. PML-RARa is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival. Blood 2004, 103:1815-1822.
38. Toma J.G., McKenzie I.A., Bagli D., Miller F.D. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 2005, 23:727-737.
39. Tong C.K., Vellasamy S., Tan B.C., Abdullah M., Vidyadaran S., Seow H.F., Ramasamy R. Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell Biology International 2011, 35:221-226.
40. Tsukamoto S., Honoki K., Fujii H., Tohma Y., Kido A., Mori T., Tsujiuchi T., Tanaka Y. Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model. International Journal of Oncology 2012, 40:163-169.
41. Unger C., Gao S., Cohen M., Jaconi M., Bergstrom R., Holm F., Galan A., Sanchez E., Irion O., Dubuisson J.B., Giry-Laterriere M., Salmon P., Simon C., Hovatta O., Feki A. Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells. Human Reproduction 2009, 24:2567-2581.
42. Vishnubalaji R., Manikandan M., Al-Nbaheen M., Kadalmani B., Aldahmash A., Alajez N.M. In vitro differentiation of human skin-derived multipotent stromal cells into putative endothelial-like cells. BMC Developmental Biology 2012, 12:7.
43. Volz K.S., Miljanm E., Khoo A., Cooke J.P. Development of pluripotent stem cells for vascular therapy. Vascular Pharmacology 2012, 56:288-296.
44. Wada N., Bartold P.M., Gronthos S. Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells. Stem Cells and Development 2011, 20:647-659.
45. Wulf G.G., Chapuy B., Trumper L. Mesenchymal stem cells from bone marrow. Phenotype, aspects of biology, and clinical perspectives. Medizinische Klinik (Munich, Germany) 2006, 101:408-413.
46. Xu W., Zhang X., Qian H., Zhu W., Sun X., Hu J., Zhou H., Chen Y. Mesenchymal stem cells from adult human bone marrow differentiated into cardiomyocytes in vitro. Experimental Biology and Medicine (Maywood, N.J.) 2004, 229:623-631.
47. Zhu W., Xu W., Jiang R., Qian H., Chen M., Hu J., Cao W., Han C., Chen Y. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Experimental and Molecular Pathology 2006, 80:267-274.
48. Zhu W., Huang L., Li Y., Qian H., Shan X., Yan Y., Mao F., Wu X., Xu W.R. Mesenchymal stem cell-secreted soluble signaling molecules potentiate tumor growth. Cell Cycle 2011, 10:3198-3207.
49. Zhu W., Huang L., Li Y., Zhang X., Gu J., Yan Y., Xu X., Wang M., Qian H., Xu W. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Letters 2012, 315:28-37.